Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis

PJ Kotyla, B Sliwinska-Kotyla, EJ Kucharz - Clinical rheumatology, 2007 - Springer
Sir, We have read with the interest the paper of Tektonidu et al.[1] reporting the two cases of
peripheral neuropathy in patients with rheumatoid arthritis treated with anti-tumor necrosis …

Therapeutic potential of HMG-CoA reductase inhibitors (statins) in systemic lupus erythematosus

P Kotyla, B Sliwinska-Kotyla - Progress in systemic lupus …, 2008 - books.google.com
Systemic lupus erythematosus is a connective tissue disorder of unknown origin and a
relatively bad prognosis. In the last fifty years the big progress in the treatment of the condition …

[CITATION][C] Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.

PJ Kotyla, B Sliwinska-Kotyla, EJ Kucharz - The Journal of …, 2006 - jrheum.org
www.jrheum.org Downloaded on November 23, 2023 from Page 1 Should Physicians
Manipulate Their Assessment Tools? No, They Shouldn’t! To the Editor: I read with great …

[PDF][PDF] Role of hydroxymethyl-glutharyl CoA reductase inhibitors (statins) in rheumatology

PJ Kotyla, B Śliwińska-Kotyla, M Lewicki… - Reumatologia … - termedia.pl
Znaczenie inhibitorów hydroksymetyloglutarylo-koenzymu A (statyn) w reumatologii Page 1
Reumatologia 2005; 43/1 Znaczenie inhibitorów hydroksymetyloglutarylo-koenzymu A (…

[CITATION][C] Risk of atherosclerosis development in patients with systemic lupus erythematosus

PJ Kotyla, B Sliwińska-Kotyla, M Lewicki… - Polskie Archiwum …, 2005 - europepmc.org
[Risk of atherosclerosis development in patients with systemic lupus erythematosus]. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

[BOOK][B] Progress in Systemic Lupus Erythematosus Research

TI Seward - 2007 - books.google.com
This new book is devoted to leading-edge research developments in lupus which is a condition
of chronic inflammation caused by an autoimmune disease. Autoimmune diseases are …

[PDF][PDF] Znaczenie inhibitorów hydroksymetyloglutarylo-koenzymu A (statyn) w reumatologii

PJ Kotyla, B Śliwińska-Kotyla, M Lewicki, EJ Kucharz - Reumatologia, 2005 - termedia.pl
Inhibitory hydroksymetyloglutarylo-koenzymu A charakteryzują się wysoką skutecznoœcią
w prewencji pierwotnej i wtórnej chorób układu sercowo-naczyniowego. W ostatnich latach …

[CITATION][C] The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans

PJ Kotyla, B Sliwińska-Kotyla… - Polskie Archiwum …, 2002 - pubmed.ncbi.nlm.nih.gov
… 1 , Bogna Sliwińska-Kotyla, Eugeniusz J Kucharz …

[CITATION][C] T he First Polish–Lithuanian Conference on Internal Medicine

EJ Kucharz - European Journal of Internal Medicine, 2003

Inzidente neuropathische Symptome unter Behandlung der rheumatoiden Arthritis mit Leflunomid

K Höhne - 2013 - refubium.fu-berlin.de
Mit einer Prävalenz von 0,5% bis 0,8% unter der erwachsenen Bevölkerung ist die rheumatoide
Arthritis die wichtigste entzündlich-rheumatische Gelenkerkrankung in Deutschland. Bei …